Jla Biopharma Consulting LLC entered the industry of Business Consultants in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541618, which describes it as a Business Consultants. For further clarification, the SIC classifies this business under the code 8748 and described it as a Business Consultants. The business provides service to the B2B market.
To acquire more information, please contact Jennifer Agahigian by calling (508) 479-7919 during business hours. You can also write to the business’ Single Location at 1783 Washington St, Walpole, Massachusetts MA 02081. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Jla Biopharma Consulting LLC |
Representative: | Jennifer Agahigian |
Place of Business: | 1783 Washington St, Walpole, MA 02081 |
Contact Number: | (508) 479-7919 |
Type of Service: | Business Consultants |
SIC Number: | 8748 |
NAICS Number: | 541618 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2009 |
Income/Year: | $50.000 to $99.999 |
Laborers: | 1 to 4 |
Share This Company: |
Jla Biopharma Consulting LLC is a company operating from Norfolk, Massachusetts providing professional Business Consultants and relevant B2B variables. It was founded in 2009 and registered with the SIC code 8748 as Business Consultants, and with the NAICS code 541618 as Business Consultants.
With a current employee count of 1 to 4, Jla Biopharma Consulting LLC has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Jennifer Agahigian at (508) 479-7919 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 1783 Washington St in Walpole, Massachusetts 02081 and can be engaged online through the company website at , the company Twitter , and Facebook page .